Skip to main content

ONWRY · Onward Medical N.V. · Documents

Track ONWRY — free
$2.11 +0.00 (+0.00%) At close · Nov 6 Play latest call Q3 2026 earnings call transcript
Volume · Nov 6 1100 Avg daily vol (3M) 3897

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Earnings call New Q3 2026 earnings call Held Nov 3, 2026
2026
Nov 3
Earnings call
Archex systems grew 120% as revenue reached 2.5 million euros

Onward sold or supplied 88 Archex systems via paid evaluation in Q3, up 120% year over year, and reported 2.5 million euros in revenue. The company ended with 73.4 million euros in cash; Empower BP enrollment reached 31 participants.

5 source passages
Welcome to Onward's webcast. So, 88 Archex systems were sold or supplied via paid evaluation in Q3. That's 120% year-over-year growth. Revenue in the third quarter was 2.5 million euros, of which product revenue was 2 million euros. Our current cash balance at the end of the third quarter was 73.4 million euros. We have 31 participants enrolled in the study to date. Open the document at this passage
Showing 1–3 of 3 documents
Key facts CIK 2059986 CUSIP 68339U102 Visit website Investor relations